CVS Health reports strong Q2 2026 results and raises full-year guidance
CVS Health reported second-quarter 2026 revenues of $106.1 billion and raised its full-year GAAP adjusted EPS and cash flow guidance to reflect growth in the Health Care Benefits and Pharmacy & Consumer Wellness segments, despite caution regarding cost trends.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day